Cochlear Limited
COH
Rangering i aksjer
#2958
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Aksjekurs
$96.06
Sist synkronisert: 2026-10-19
Markedsverdi
$6.28B
Endring (1 dag)
3.06%
Endring (1 år)
-48.66%
Land
AU
Handel Cochlear Limited (COH)
Kategori
Healthcare
EPS for Cochlear Limited (COH)
EPS per June 2026 TTM: $1.59
Ifølge de siste økonomiske rapportene og aksjekursen til Cochlear Limited er selskapets nåværende EPS (TTM) $1.59. Ved slutten av 2024 hadde selskapet en EPS på $3.63, en økning sammenlignet med EPS-en i 2023 som var $3.04.
EPS-historikk for Cochlear Limited fra 2000 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $1.59 | -59.41% |
| 2025 | $3.91 | 7.65% |
| 2024 | $3.63 | 19.29% |
| 2023 | $3.04 | 0.33% |
| 2022 | $3.03 | -17.90% |
| 2021 | $3.70 | -229.72% |
| 2020 | $-2.85 | -184.36% |
| 2019 | $3.38 | 6.57% |
| 2018 | $3.17 | 5.55% |
| 2017 | $3.00 | 21.79% |
| 2016 | $2.47 | 25.10% |
| 2015 | $1.97 | 26.64% |
| 2014 | $1.56 | -26.90% |
| 2013 | $2.13 | 108.34% |
| 2012 | $1.02 | -70.03% |
| 2011 | $3.41 | 45.88% |
| 2010 | $2.34 | 23.46% |
| 2009 | $1.89 | -5.11% |
| 2008 | $2.00 | 28.41% |
| 2007 | $1.55 | 42.34% |
| 2006 | $1.09 | 43.49% |
| 2005 | $0.76 | 61.08% |
| 2004 | $0.47 | -35.97% |
| 2003 | $0.74 | 70.03% |
| 2002 | $0.43 | 42.23% |
| 2001 | $0.31 | 27.35% |
| 2000 | $0.24 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $3.11 | 95.98% |
US
|
|
| $3.59 | 126.23% |
IE
|
|
| $9.73 | 513.15% |
US
|
|
| $2.48 | 56.28% |
US
|
|
| - | - |
DE
|
